phorbol 12,13-dibutyrate has been researched along with ALS - Amyotrophic Lateral Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacques, D; Krieger, C; Parent, A; Quirion, R | 1 |
| Krieger, C; Lanius, RA; Shaw, CA; Wagey, R | 1 |
2 other study(ies) available for phorbol 12,13-dibutyrate and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
[3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Autoradiography; Humans; In Vitro Techniques; Phorbol 12,13-Dibutyrate; Protein Kinase C; Spinal Cord; Substantia Gelatinosa | 1995 |
Activation of PKC reverses apparent NMDA receptor reduction in ALS.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Amyotrophic Lateral Sclerosis; Autoradiography; Dizocilpine Maleate; Enzyme Activation; Humans; In Vitro Techniques; Isoquinolines; Phorbol 12,13-Dibutyrate; Piperazines; Protein Kinase C; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 1993 |